Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: T3
Thanks for commenting. And as you alluded to in one of your prior posts, it would be investor-friendly for PTSC to disclose to shareholders how they are going to maximize MMP ROI. Inform investors as to how they will safe-guard their 50% of the MMP without allowing TPL to fraudulently commingle licenses. These are core issues that should be addressed to attract any investment, unless they are confident of a large return from the T3. Then find a way to communicate to longtime shareholders who deserve honest communication that brighter days are ahead. And please do not put together a series of announcements to manipulate the share price like what happened when the 336 was reconfirmed.
Share
New Message
Please login to post a reply